Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Ward

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 12, 2009
Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancersDeborah Packham, Robyn L Ward, Vita Ap Lin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2012
Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family RegistryRobyn L Ward, Timothy Dobbins, Noralane M Lindor, et al.
Pharmacoeconomics|April 2, 2015
Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential SolutionsGerardus W J Frederix, Hossein Haji Ali Afzali, Erik J Dasbach, et al.
Nature Reviews. Clinical Oncology|November 10, 2010
The role of BRCA mutation testing in determining breast cancer therapyAlison H Trainer, Craig R Lewis, Kathy Tucker, et al.
Clinical Epigenetics|December 23, 2014
Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patientsMathew A Sloane, Luke B Hesson, Andrea C Nunez, et al.
Australian and New Zealand Journal of Public Health|February 6, 2014
Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: a record linkage studyClaire M Vajdic, Efty P Stavrou, Robyn L Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2011
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancerBarbara-Ann Adelstein, Timothy A Dobbins, Carole A Harris, et al.
The Medical Journal of Australia|November 23, 2006
Off-label use of medicines: consensus recommendations for evaluating appropriatenessMadlen Gazarian, Maria Kelly, John R McPhee, et al.
Breast (Edinburgh, Scotland)|May 14, 2013
Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?Christine Y Lu, Preeyaporn Srasuebkul, Anna K Drew, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Predictors of care for patients with cancer of unknown primary site in three Australian hospitalsSimon Y S Tan, Siobhan O'Neill, David Goldstein, et al.
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 12, 2009
Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancersDeborah Packham, Robyn L Ward, Vita Ap Lin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2012
Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family RegistryRobyn L Ward, Timothy Dobbins, Noralane M Lindor, et al.
Pharmacoeconomics|April 2, 2015
Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential SolutionsGerardus W J Frederix, Hossein Haji Ali Afzali, Erik J Dasbach, et al.
Nature Reviews. Clinical Oncology|November 10, 2010
The role of BRCA mutation testing in determining breast cancer therapyAlison H Trainer, Craig R Lewis, Kathy Tucker, et al.
Clinical Epigenetics|December 23, 2014
Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patientsMathew A Sloane, Luke B Hesson, Andrea C Nunez, et al.
Australian and New Zealand Journal of Public Health|February 6, 2014
Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: a record linkage studyClaire M Vajdic, Efty P Stavrou, Robyn L Ward, et al.
European Journal of Cancer (Oxford, England : 1990)|May 10, 2011
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancerBarbara-Ann Adelstein, Timothy A Dobbins, Carole A Harris, et al.
The Medical Journal of Australia|November 23, 2006
Off-label use of medicines: consensus recommendations for evaluating appropriatenessMadlen Gazarian, Maria Kelly, John R McPhee, et al.
Breast (Edinburgh, Scotland)|May 14, 2013
Trastuzumab therapy in Australia: which patients with HER2+ metastatic breast cancer are assessed for cardiac function?Christine Y Lu, Preeyaporn Srasuebkul, Anna K Drew, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Predictors of care for patients with cancer of unknown primary site in three Australian hospitalsSimon Y S Tan, Siobhan O'Neill, David Goldstein, et al.
Pageof 16